Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease
2015 ◽
2017 ◽
Vol 15
(1)
◽
2019 ◽
Vol 3
(1)
◽
pp. 121-122